Modeling Multicancer Screening-Reference-Cited by-同舟云学术

Modeling Multicancer Screening

Published:2022-01-01 Issue:1 Volume:31 Page:3-4
ISSN:1055-9965
Container-title:Cancer Epidemiology, Biomarkers & Prevention
language:en
Short-container-title:

Author:

Duffy Stephen W.¹^ORCID,Sasieni Peter²

Affiliation:

1. 1Centre for Cancer Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, United Kingdom.

2. 2School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.

Abstract

Abstract Jiao and colleagues have developed an estimation framework for measuring the benefits of a multi-cancer screening test, notably in terms of cancer detection and deaths prevented. The approach is clear and attractive. Further developments are likely to include more flexible modeling of sensitivities and specificities. See related article by Jiao et al., p. 38

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Link

https://aacrjournals.org/cebp/article-pdf/31/1/3/3019149/3.pdf

Reference6 articles.

1. Should a standard be defined for the positive predictive value (PPV) of recall in the UK NHS Breast Screening Programme?;Bennett;Breast,2007

2. A simple framework to identify optimal cost-effective risk thresholds for a single screen: comparison to decision curve analysis;Katki;J Roy Stat Soc A,2021

3. The evaluation of cancer screening: concepts and outcome measures;Duffy;Med Clin North Am,2020

4. Estimating prevalence when the true disease status is incompletely ascertained;Sasieni;Stat Med,2001

5. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA;Liu;Ann Oncol,2020